ADHD Medication Guide: Non-Stimulant Treatment Options

ADHD can be effectively managed with non-stimulant medications. These options provide symptom relief for Alaskans without the concerns associated with controlled substances. This guide explains your non-stimulant treatment options.

Non-Stimulant ADHD Medications

AlaskaDoc prescribes non-stimulant medications that effectively manage ADHD symptoms:

Atomoxetine (Strattera)

The primary non-stimulant option for ADHD:

Mechanism: Selective norepinephrine reuptake inhibitor
Benefits: 24-hour coverage, no abuse potential
Timeline: 4-8 weeks for full effect
Dosing: Once or twice daily

Alpha-2 Agonists

Originally for blood pressure, now FDA-approved for ADHD:

Guanfacine ER (Intuniv): Once-daily, helps with impulsivity
Clonidine ER (Kapvay): Twice-daily, also helps with tics

Why Non-Stimulant? Non-stimulant medications offer effective ADHD treatment without scheduling restrictions, abuse potential, or stimulant side effects like appetite suppression and insomnia.
        

How These Medications Help

Non-stimulant ADHD medications improve:

Attention and focus: Sustained concentration on tasks
Impulse control: Better decision-making, less interrupting
Hyperactivity: Reduced restlessness and fidgeting
Working memory: Better retention of information
Emotional regulation: More stable mood responses

Comparing Non-Stimulant Options

Atomoxetine (Strattera)

Best for: Adults and children who can't take stimulants
Pros: 24-hour coverage, helps with anxiety
Cons: Takes weeks to work, may cause initial nausea

Guanfacine ER (Intuniv):

Best for: Hyperactivity and impulsivity
Pros: Once daily, calm focus, helps with sleep
Cons: May cause drowsiness, blood pressure effects

Clonidine ER (Kapvay):

Best for: ADHD with tics or aggression
Pros: Helps with sleep, reduces tics
Cons: Twice-daily dosing, sedation possible

Treatment Timeline

Atomoxetine:

Week 1-2: Gradual dose increase
Week 3-4: Some improvement begins
Week 6-8: Full therapeutic effect

Alpha-2 Agonists:

Week 1: Start low dose
Week 2-3: Gradual increases
Week 4-6: Optimal dose reached

Side Effect Management

Atomoxetine common side effects:

Upset stomach: Take with food
Decreased appetite: Usually temporary
Fatigue: May improve with evening dosing
Mood changes: Monitor and report

Alpha-2 agonist side effects:

Drowsiness: Usually improves over time
Low blood pressure: Monitor if symptomatic
Dry mouth: Stay hydrated

ADHD Treatment in Alaska

Alaska allows licensed physicians to prescribe non-controlled ADHD medications via telehealth. This provides convenient access to ongoing ADHD management for Alaskans.

AlaskaDoc ADHD Care

Approach: Comprehensive evaluation and personalized treatment

Monitoring: Regular follow-ups to optimize medication and address concerns

Get Expert Care at AlaskaDoc

Medical Disclaimer: This is educational content only. All medical decisions should be made with licensed physicians. Individual results vary. Seek immediate care for emergencies.

Who this is for in Alaska

This article is for those patients when they are deciding whether ADHD Medication Guide: Non-Stimulant Treatment Options fits a visit with AlaskaDoc.

How the AlaskaDoc visit applies

The AlaskaDoc visit for this topic starts with a structured intake covering symptoms, medications, allergies, and prior treatment response. An Alaska-licensed physician (AK) reviews whether ADHD Medication Guide: Non-Stimulant Treatment Options is appropriate, whether labs are required, and whether another approach is safer. If a prescription is indicated, it is sent to a pharmacy the patient can use in Alaska. That prescription is not a referral to a Seattle or other Lower 48 clinic treated as if it were in Alaska.

Local access

A patient in Anchorage, Fairbanks, and Juneau should compare ADHD Medication Guide: Non-Stimulant Treatment Options with care already available through Providence Alaska Medical Center or the Alaska Native Medical Center, not with a Seattle or other Lower 48 clinic treated as if it were in Alaska. Labs, when needed, can be drawn through a local partner in Alaska.